Nautilus Biotechnology In...

NASDAQ: NAUT · Real-Time Price · USD
0.71
-0.01 (-1.63%)
At close: Aug 15, 2025, 3:59 PM
0.71
-0.18%
After-hours: Aug 15, 2025, 04:32 PM EDT

Nautilus Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a 8.21M 8.21M 8.21M 8.21M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1.61M 3.21M 4.8M 6.39M 6.29M 6.12M 5.7M 5.03M 3.51M 2.92M 2.56M 1.9M 1.9M 1.37M 563K 300K 300K n/a
Gross Profit
-1.61M -3.21M -4.8M -6.39M -6.29M -6.12M -5.7M -5.03M -3.51M -2.92M -2.56M -1.9M -2.17M -1.65M -840K -577K -300K n/a
Operating Income
-39.08M -78.71M -81.48M -81.5M -81.47M -79.7M -76.15M -72.45M -69.2M -65.66M -63.62M -64.13M -62.88M -58.1M -50.5M -39M -28.46M -21.16M
Interest Income
9.42M 10.13M 10.78M 11.38M 11.9M 12.33M 12.55M 12.4M 11.1M 8.65M 5.82M 2.93M 1.18M 400K 136K 136K n/a n/a
Pretax Income
-65.69M -68.66M -70.78M -70.21M -69.64M -67.44M -63.67M -60.06M -58.24M -57.13M -57.92M -61.2M -61.65M -57.67M -50.31M -38.98M -28.45M -21.09M
Net Income
-65.69M -68.66M -70.78M -70.21M -69.64M -67.44M -63.67M -60.06M -58.24M -57.13M -57.92M -61.2M -61.65M -57.67M -50.31M -38.98M -28.45M -21.09M
Selling & General & Admin
27.98M 29.63M 31M 31.38M 31.64M 30.39M 28.9M 28.08M 27.25M 26.77M 25.95M 26.15M 26.23M 23.93M 21.15M 15.65M 10.04M 6.37M
Research & Development
47.04M 49.08M 50.48M 50.12M 49.83M 49.3M 47.25M 44.37M 41.95M 38.89M 37.67M 37.98M 36.65M 34.17M 29.35M 23.35M 18.43M 14.8M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
75.02M 78.71M 81.48M 81.5M 81.47M 79.7M 74.98M 71.28M 68.03M 64.48M 63.62M 64.13M 62.88M 57.8M 50.2M 38.7M 28.16M 21.16M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
57.92M 78.71M 81.48M 81.5M 81.47M 79.7M 76.15M 72.45M 69.2M 65.66M 63.62M 64.13M 62.88M 58.1M 50.5M 39M 28.46M 21.16M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
126.17M 124.92M 125.8M 125.45M 125.32M 125.14M 124.98M 124.93M 124.6M 124.59M 124.79M 124.65M 124.49M 124.42M 124.23M 124.11M 55.07M 33M
Shares Outstanding (Diluted)
126.17M 124.92M 125.8M 125.45M 125.32M 125.14M 124.98M 124.93M 124.6M 124.59M 124.79M 124.65M 124.49M 124.42M 124.23M 124.11M 55.07M 33M
EPS (Basic)
-0.52 -0.54 -0.56 -0.56 -0.56 -0.55 -0.52 -0.49 -0.47 -0.46 -0.47 -0.49 -0.5 -0.57 -0.69 -0.73 -0.74 -0.67
EPS (Diluted)
-0.52 -0.54 -0.56 -0.56 -0.56 -0.55 -0.52 -0.49 -0.47 -0.46 -0.47 -0.49 -0.5 -0.57 -0.69 -0.73 -0.74 -0.67
EBITDA
-35.91M -72.33M -75.12M -75.11M -75.21M -73.57M -70.45M -67.42M -64.79M -61.88M -60.2M -61.37M -60.7M -56.47M -49.05M -37.22M -26.37M -19.18M
EBIT
-57.92M -78.71M -81.48M -81.5M -81.47M -79.7M -73.06M -69.36M -66.11M -62.56M -63.62M -64.13M -62.88M -58.1M -50.5M -39M -28.46M -21.16M
Depreciation & Amortization
3.17M 6.39M 6.35M 5.37M 5.24M 5.06M 4.64M 5M 4.37M 3.78M 3.42M 2.76M 2.17M 1.65M 1.47M 1.8M 2.11M 1.98M